Goldman Sachs’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $12K | Sell |
|
|||||
|
2022
Q2 | $211K | Buy |
|
|||||
|
2022
Q1 | $233K | Buy |
|
|||||
|
2021
Q4 | $379K | Buy |
|
|||||
|
2021
Q3 | $434K | Buy |
|
|||||
|
2021
Q2 | $105K | Sell |
|
|||||
|
2021
Q1 | $899K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $89K | Buy |
|
|||||
|
2019
Q1 | $64K | Sell |
|
|||||
|
2018
Q4 | $62K | Buy |
|
|||||
|
2018
Q3 | $37K | Buy |
|
|||||
|
2018
Q2 | $157K | Sell |
|
|||||
|
2018
Q1 | $812K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $36K | Sell |
|
|||||
|
2016
Q2 | $29K | Buy |
|
|||||
|
2016
Q1 | $10K | Sell |
|
|||||
|
2015
Q4 | $17K | Buy |
|
|||||
|
2015
Q3 | $14K | Sell |
|
|||||
|
2015
Q2 | $49K | Hold |
|
|||||
|
2015
Q1 | $23K | Sell |
|
|||||
|
2014
Q4 | $32K | Sell |
|
|||||
|
2014
Q3 | $65K | Sell |
|
|||||
|
2014
Q2 | $153K | Buy |
|
|||||
|
2014
Q1 | $136K | Buy |
|
|||||
|
2013
Q4 | $140K | Buy |
|
|||||
|
2013
Q3 | $86K | Buy |
|
|||||
|
2013
Q2 | $264K | Buy |
|